Ligand Pharmaceuticals Inc <LGND.O>: Benchmark Raises Target Price to $335 from $275
LGND•Related News
Lennar launches Sutton and Hollis single-family home collections at Valencia, California community
LEN•
Landmark Bancorp director Mark J. Kohlrus acquires USD 31,807.70 in common shares
LARK•
New Colombia president pledges robust fight against crime, fiscal austerity in maiden speech
EC•
Berkshire accelerates buybacks, lowers cash stake as profit tops forecasts
BRK.B•
Nvidia to invest up to $3 billion in Lancium, the Information reports
NVDA•